ANZSN renal supportive care guidelines 2013

Nephrology

Volumn 18, Issue 6, 2013, Pages 401-454

  Brown, Mark A ^a   Crail, Susan M ^b   Masterson, Rosemary ^c   Foote, Celine ^d   Robins, Jennifer ^a   Katz, Ivor ^a   Josland, Elizabeth ^e   Brennan, Frank ^e   Stallworthy, Elizabeth J ^f   Siva, Brian ^g   Miller, Cathy ^h   Urban, A Katalin ⁱ   Sajiv, Cherian ^j   Glavish, R Naida ^k   May, Steven ^l   Langham, Robyn ^m   Walker, Robert ⁿ   Fassett, Robert G ^o   Morton, Rachael L ^p   Stewart, Cameron ^q   Phipps, Lisa ^r   Healy, Helen ^o   Berquier, Ilse ^b   more..

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Central and Northern Adelaide Renal and Transplantation Service   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e ST GEORGE HOSPITAL   (Australia)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g FREMANTLE HOSPITAL   (Australia)

^h WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

ⁱ Department of Microbiology and Infectious Diseases   (Australia)

^j ALICE SPRINGS HOSPITAL   (Australia)

^k AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^l Tamworth Base Hospital   (Australia)

^m ST VINCENT S HOSPITAL   (Australia)

ⁿ UNIVERSITY OF OTAGO   (New Zealand)

^o ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^p UNIVERSITY OF SYDNEY   (Australia)

^q UNIVERSITY OF SYDNEY   (Australia)

^r Orange Base Hospital   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ANOREXIA; ANXIETY; BREAST CANCER; CAREGIVER; CEREBROVASCULAR DISEASE; COMORBIDITY; CONSTIPATION; CORONARY ARTERY DISEASE; CULTURAL FACTOR; DEATH; DEPRESSION; DIALYSIS; DYING; DYSPNEA; EVIDENCE BASED MEDICINE; EXPECTATION; FAMILY COUNSELING; FATIGUE; FUNCTIONAL STATUS; GERIATRIC PATIENT; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTESTINE CANCER; KIDNEY CANCER; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUNG CANCER; MALNUTRITION; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL STAFF; MODIFIED CHARLSON SCORE; MORTALITY; NAUSEA; NEPHROLOGIST; NURSING STAFF; NUTRITIONAL STATUS; OVARY CANCER; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PERIPHERAL VASCULAR DISEASE; PERSONALIZED MEDICINE; POST TREATMENT SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PRURITUS; QUALITY OF LIFE; RELIGION; RENAL REPLACEMENT THERAPY; RESTLESS LEGS SYNDROME; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SHORT FORM 36; SLEEP DISORDER; SURVIVAL RATE; SYMPTOM ASSESSMENT; TERMINAL CARE; TREATMENT PLANNING;

ADVANCE CARE PLANNING; AGE FACTORS; AGED; ATTITUDE TO DEATH; COMORBIDITY; COST OF ILLNESS; DECISION SUPPORT TECHNIQUES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NEPHROLOGY; PALLIATIVE CARE; PATIENT SELECTION; QUALITY OF LIFE; RELIGION; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SPIRITUALITY; TIME FACTORS; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 84878283552     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12065     Document Type: Review

References (228)

1. ANZDATA Annual Report 2011.
2. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farringdon K,. Survival of elderly patients with stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 2011; 26: 1608-1614.
3. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative Care to treat end-stage kidney disease. CMAJ 2012; 184: E277-283.
4. Leiva-Santos JP, Sanchez-Hernandez R, Garcia-Llana H, et al. Renal supportive care and palliative care: Revision and proposal in kidney replacement therapy. Nefrologia 2012; 32: 20-27.
5. Swidler M,. Geriatric renal palliative care is coming of age. Int. Urol. Nephrol. 2010; 42: 851-855.
6. Tamura MK, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE,. Functional status of elderly adults before and after initiation of dialysis. N. Engl. J. Med. 2009; 361: 1539-1547.
7. Davison SN,. End-of-life preferences and needs: Perceptions of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010; 5: 195-204.
8. Davison SN, Simpson C,. Hope and advance care planning in patients with end-stage renal disease: Qualitative interview study. BMJ 2006; 333: 886.
9. Kurella M, Covinsky KE, Collins AJ, Chertow GM,. Octogenarians and nonagenarians starting dialysis in the United States. Ann. Intern. Med. 2007; 146: 177-183. (Pubitemid 351650630)
10. Krishnan M, Lok CE, Jassal SV,. Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Semin. Dial 2002; 15: 79-83. (Pubitemid 41749878)
11. ANZDATA. Registry Report Volume 33. Adelaide, SA: Australia and New Zealand Dialysis and Transplant Registry, 2010.
12. Morton RL, Howard K, Webster AC, Snelling P,. Patient INformation about Options for Treatment (PINOT): A prospective national study of information given to incident CKD Stage 5 patients. Nephrol. Dial. Transplant. 2011; 26: 1266-1274.
13. Australian Institute of Health and Welfare. An Overview of Chronic Kidney Disease in Australia, 2009. Cat. no. PHE 111. Canberra: AIHW, 2009.
14. Visser A, Dijkstra GJ, Kuiper D, et al. Accepting or declining dialysis: Considerations taken into account by elderly patients with end-stage renal disease. J. Nephrol. 2009; 22: 794-799.
15. Ashby M, op't Hoog C, Kellehear A, et al. Renal dialysis abatement: Lessons from a social study. Palliat. Med. 2005; 19: 389-396. (Pubitemid 41150267)
16. Foote C, Ninomiya T, Gallagher M, et al. Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol. Dial. Transplant. 2012; 27: 3581-3587.
17. Carson RC, Juszczak M, Davenport A, Burns A,. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin. J. Am. Soc. Nephrol. 2009; 4: 1611-1619.
18. Murtagh FEM, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE,. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 2007; 22: 1955-1962. (Pubitemid 47244766)
19. Joly D, Anglicheau D, Alberti C, et al. Octogenarians reaching end-stage renal disease: Cohort study of decision-making and clinical outcomes. J. Am. Soc. Nephrol. 2003; 14: 1012-1021. (Pubitemid 36359283)
20. Australia's Health 2008. Cat. no. AUS 99. Canberra: AIHW, 2008. [Cited 10 Feb 2011]. Available from URL: www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id= 6442453674.2008
21. Couchoud C, Labeeuw M, Moranne O, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol. Dial. Transplant. 2009; 24: 1553-1561.
22. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE,. Functional status of elderly adults before and after initiation of dialysis. N. Engl. J. Med. 2009; 361: 1539-1547.
23. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K,. Choosing not to dialyse: Evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron 2003; 95: c40-6.
24. Ellam T, El-Kossi M, Prasanth KC, El-Nahas M, Khwaja A,. Conservatively managed patients with stage 5 chronic kidney disease-Outcomes from a single center experience. QJM 2009; 102: 547-554.
25. Wong CF, McCarthy M, Howse MLP, Williams PS,. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. (Erratum appears in Ren. Fail. 2008; 30: 343.). Ren. Fail. 2007; 29: 653-659. (Pubitemid 47346982)
26. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K,. Survival of elderly patients with stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 2010; 26: 1608-1614.
27. Lamping DL, Constantinovici N, Roderick P, et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: A prospective cohort study. Lancet 2000; 356: 1543-1550.
28. Rebollo P, Ortega F, Baltar JM, Alvarez-Ude F, Alvarez Navascues R, Alvarez-Grande J,. Is the loss of health-related quality of life during renal replacement therapy lower in elderly patients than in younger patients? Nephrol. Dial. Transplant. 2001; 16: 1675-1680. (Pubitemid 32750463)
29. Rohrich B, von Herrath D, Asmus G, Schaefer K,. The elderly dialysis patient: Management of the hospital stay. Nephrol. Dial. Transplant. 1998; 13 (Suppl 7): 69-72. (Pubitemid 28534778)
30. Jassal SV, Chiu E, Hladunewich M,. Loss of independence in patients starting dialysis at 80 years of age or older. N. Engl. J. Med. 2009; 361: 1612-1613.
31. Belasco A, Barbosa D, Bettencourt AR, Diccini S, Sesso R,. Quality of life of family caregivers of elderly patients on hemodialysis and peritoneal dialysis. Am. J. Kidney Dis. 2006; 48: 955-963. (Pubitemid 44895369)
32. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305: 1553-1559. Epub 13 April 2011.
33. Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R,. Palliative care in end-stage kidney disease. Nephrology (Carlton) 2011; 16: 4-12. Epub 24 December 2010.
34. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K,. Choosing not to dialyse: Evaluation of planned non-dialytic management in a cohort of patients with end-stage renal failure. Nephron Clin. Pract. 2003; 95: c40-6. Epub 12 November 2003.
35. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE,. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 2007; 22: 1955-1962. Epub 7 April 2007. (Pubitemid 47244766)
36. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA,. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am. J. Kidney Dis. 2003; 42: 125-132. Epub 28 June 2003. (Pubitemid 36807661)
37. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE,. Functional status of elderly adults before and after initiation of dialysis. N. Engl. J. Med. 2009; 361: 1539-1547. Epub 16 October 2009.
38. Collins GS, Omar O, Shanyinde M, Yu L-M,. A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J. Clin. Epidemiol. 2013; 66: 268-277.
39. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987; 40: 373-383. Epub 1 January 1987. (Pubitemid 17055592)
40. Cohen LM, Ruthazer R, Moss AH, Germain MJ,. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 2010; 5: 72-79. Epub 8 December 2009.
41. Kidney Health Australia K. Fast Facts on CKD in Australia. Kidney Health Australia; 2012 [updated March 2012; cited 11 Nov 2012.] Available from URL: http://www.kidney.org.au/Kidneydisease/FastFactsonCKD/tabid/589/Default.aspx
42. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB,. Survival advantages of obesity in dialysis patients. Am. J. Clin. Nutr. 2005; 81: 543-554.
43. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL,. The effect of age on the association between body-mass index and mortality. N. Engl. J. Med. 1998; 338: 1-7. (Pubitemid 28040168)
44. Wong CF, McCarthy M, Howse ML, Williams PS,. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren. Fail. 2007; 29: 653-659. Epub 1 September 2007. (Pubitemid 47346982)
45. Moss AH,. Too many patients who are too sick to benefit start chronic dialysis nephrologists need to learn to 'just say no'. Am. J. Kidney Dis. 2003; 41: 723-727. Epub 1 April 2003.
46. Geddes CC, van Dijk PC, McArthur S, et al. The ERA-EDTA cohort study-Comparison of methods to predict survival on renal replacement therapy. Nephrol. Dial. Transplant. 2006; 21: 945-956. Epub 13 December 2005.
47. Moss AH, Ganjoo J, Sharma S, et al. Utility of the 'surprise' question to identify dialysis patients with high mortality. Clin. J. Am. Soc. Nephrol. 2008; 3: 1379-1384. Epub 4 July 2008.
48. Couchoud C,. Dialysis: Can we predict death in patients on dialysis? Nat. Rev. Nephrol. 2010; 6: 388-389. Epub 30 June 2010.
49. Couchoud C, Labeeuw M, Moranne O, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol. Dial. Transplant. 2009; 24: 1553-1561. Epub 20 December 2008.
50. Cleary J, Drennan J,. Quality of life of patients on haemodialysis for end-stage renal disease. J. Adv. Nurs. 2005; 51: 577-586. (Pubitemid 41296802)
51. Josland E, Brennan F, Anastasiou A, Brown MA,. Developing and sustaining a renal supportive care service for people with end-stage kidney disease. Ren. Soc. Australas. J. 2012; 8: 11-17.
52. Chandna S, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood R, Farrington K,. Survival of elderly patients with stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 2010; 26: 1608-1614.
53. Rosenberger J, van Dijk J, Nagyova I, et al. Do dialysis and transplantation-related medical factors affect perceived health status? Nephrol. Dial. Transplant. 2005; 20: 2153-2158. (Pubitemid 41510091)
54. Caskey F, Wordsworth S, Ben T, et al., Eurodice group. Early referral and planned initiation of dialysis: What impact on quality of life? Nephrol. Dial. Transplant. 2003; 18: 1330-1338. (Pubitemid 36826954)
55. White C, Pikey R, Lam M, Holland D,. Pre-dialysis clinic attendance improves quality of life among hemodialysis patients. BMC Nephrol. 2002; 3: 3. [Cited 25 September 2012.] Available from URL: http://www.biomedcentral.com/ content/pdf/1471-2369-3-3.pdf
56. Cheema B, Abas H, Smith B, et al. Progressive exercise for anabolism in kidney disease (PEAK): A randomized, controlled trial of resistance training during hemodialysis. J. Am. Soc. Nephrol. 2007; 18: 1594-1601. (Pubitemid 46729199)
57. Painter P, Carlson L, Carey S, Paul S, Myll J,. Physical functioning and health-related quality of life changes with exercise training in hemodialysis patients. Am. J. Kidney Dis. 2000; 35: 482-492.
58. Parsons T, Toffelmire E, King-Vanvlack C,. The effect of an exercise program during hemodialysis on dialysis efficacy, blood pressure and quality of life in end-stage renal disease patients. Clin. Nephrol. 2004; 61: 261-274. (Pubitemid 38477323)
59. McMahon L, Mason K, Skinner S, Burge C, Grigg L, Becker G,. Effects of hemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure. Nephrol. Dial. Transplant. 2000; 15: 1425-1430.
60. Lopes AA, Bragg J, Young E, et al., Dialysis Outcomes Practice Patterns Study. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. [Research Support, Non-U.S. Gov't]. 2002; 62: 199-207. (Pubitemid 34754063)
61. Lowrie E, Curtin R, Lepain N, Schatell D,. Medical Outcomes study short form-36: A consistent and powerful predictor of morbidity and mortality in dialysis patients. Am. J. Kidney Dis. 2003; 41: 1286-1292. (Pubitemid 36637985)
62. Mapes D, Bragg-Gresham J, Bommer J, et al. Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 2004; 44 (5 Suppl 2): S54-60. (Pubitemid 39369942)
63. Untas A, Thumma J, Rascle N, et al. The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study. Clin. J. Am. Soc. Nephrol. [Research Support, Non-U.S. Gov't]. 2011; 6: 142-152.
64. Hamilton G, Locking-Cusolito H,. Hemodialysis adequacy and quality of life: How do they relate? CANNT J. 2003; 13: 24-29.
65. Garcia-Mendoza M, Valdes C, Ortega T, Rebollo P, Ortega F,. Differences in health-related quality of life between elderly and younger patients on hemodialysis. J. Nephrol. [Clinical Trial Comparative Study Research Support, Non-U.S. Gov't]. 2006; 19: 808-818. (Pubitemid 46415988)
66. Rebollo P, Ortega F, Baltar JM, Alvarez-Ude F, Alvarez Navascues R, Alvarez-Grande J,. Is the loss of health-related quality of life during renal replacement therapy lower in elderly patients than in younger patients? Nephrol. Dial. Transplant. 2001; 16: 1675-1680. (Pubitemid 32750463)
67. Brown EA,. Can quality of life be improved for the increasing numbers of older patients with end-stage kidney disease? Expert Rev. Pharmacoecon. Outcomes Res. 2010; 10: 661-666.
68. Saini T, Murtagh FEM, Dupont PJ, McKinnon PM, Hatfield P, Saunders Y,. Comparative pilot study of symptoms and quality of life in cancer patients and patients with end stage renal disease. Palliat. Med. 2006; 20: 631-636.
69. Fassett R, Robertson I, Mace R, Youl L, Challenor S, Bull R,. Palliative care in end stage kidney disease: A review. Nephrology 2011; 16: 4-12.
70. Al-Arabi S,. Quality of life: Subjective descriptions of challenges to patients with end stage renal disease. Nephrol. Nurs. J. 2006; 33: 285-292.
71. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ [Multicenter Study Research Support, Non-U.S. Gov't]. 2012; 184: E277-283.
72. Madhan K,. Quality of life. Nephrology 2010; 15 (Suppl s4): S32-34.
73. Glover C, Banks P, Carson A, Martin CR, Duffy T,. Understanding and assessing the impact of end-stage renal disease on quality of life. Patient 2011; 4: 19-30.
74. Wilson IB, Cleary PD,. Linking clinical variables with health related quality of life: A conceptual model of patient outcomes. JAMA 1995; 273: 59-65.
75. RAND Health. Kidney Disease Quality of Life Instrument (KDQOL). 2012. [Cited 27 September 2012.] Available from URL: http://www.rand.org/health/ surveys-tools/kdqol.html
76. FACIT.org. 2010. IL, USA.
77. EuroQoL Group. EQ-5D. 2012 [24/9/2012]. [Cited 24 September 2012.] Available from URL: http://www.euroqol.org/home.html
78. World Health Organization. WHO Quality of Life-BREF (WHOQOL-BREF). 2012. [Cited 2 October 2012.] Available from URL: http://www.who.int/substance-abuse/ research-tools/whoqolbref/en/
79. Kainer G, Fetherstonhaugh D,. Ethical considerations. CARI Guidelines. Nephrology 2010; 15: S12-14.
80. Renal Physicians Association of the USA. Clinical Practice Guidelines on Shared Decision-Making in the Initiation and Withdrawal from Dialysis. Rockville, MD: Renal Physicians Association of the USA, 2020.
81. Ministry of Health. Advance Care Planning: A Guide for the New Zealand Healthcare Workforce. Wellington: New Zealand Ministry of Health, 2011.
82. McDonald S,. Deaths. In:, McDonald S, Hurst K, (eds). ANZDATA Registry Report 2011. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry, 2011; 3-1-3-7.
83. Malpas PJ,. Advance directives and older people: Ethical challenges in the promotion of advance directives in New Zealand. J. Med. Ethics 2011; 37: 285-289.
84. Detering KM, Hancock AD, Reade MC, Silvester W,. The impact of advance care planning on end of life care in elderly patients: Randomised controlled trial. BMJ 2010; 340: c1345.
85. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008; 300: 1665-1673.
86. Cukor D, Farrell EM, Cohen LM, Kimmel PL,. Psychological and psychiatric considerations in patients with advanced renal disease. In:, Chambers EJ, Brown EA, Germain MJ, (eds). Supportive Care for the Renal Patient, 2nd edn. Oxford: Oxford University Press, 2010; 189-201.
87. Davison SN, Simpson C,. Hope and advance care planning in patients with end stage renal disease: Qualitative interview study. BMJ 2006; 333: 886.
88. Braun UK, Beyth RJ, Ford ME, McCullough LB,. Voices of African American, Caucasian, and Hispanic surrogates on the burdens of end-of-life decision making. J. Gen. Intern. Med. 2007; 23: 267-274.
89. Candib LM,. Truth telling and advance care planning at the end of life: Problems with autonomy in a multicultural world. Fam. Syst. Health 2002; 20: 213-228.
90. Weiner JS, Cole SA,. Three principles to improve clinician communication for advance care planning: Overcoming emotional, cognitive, and skill barriers. J. Palliat. Med. 2004; 7: 817-829. (Pubitemid 40075665)
91. Holley JL, Carmody SS, Moss AH, et al. The need for end-of-life care training in nephrology: National survey results of nephrology fellows. Am. J. Kidney Dis. 2003; 42: 813-820. (Pubitemid 37187383)
92. Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG,. Understanding physicians' skills at providing end-of-life care: Perspectives of patients, families and healthcare workers. J. Gen. Intern. Med. 2001; 16: 41-49. (Pubitemid 32128695)
93. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalisation. N. Engl. J. Med. 2004; 351: 1296-1305.
94. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J. Am. Soc. Nephrol. 2007; 18: 2758-2765. (Pubitemid 47531203)
95. Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA,. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology 2009; 73: 920-927.
96. Clayton JM, Hancock KM, Butow PN, Tattersall MH, Currow DC,. Clinical practice guidelines for communicating prognosis and end of life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med. J. Aust. 2007; 186: S77, S79, S83-108.
97. Solano JP, Gomes B, Higginson IJ,. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive lung disease and renal disease. J. Pain Symptom Manage. 2006; 31: 58-69. (Pubitemid 43143299)
98. Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DT, Peterson RA, Switzer GE,. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J. Am. Soc. Nephrol. 2005; 16: 2487-2494. (Pubitemid 41725068)
99. Cohen LM, Moss AH, Weisbord SD, Germain MJ,. Renal palliative care. J. Palliat. Med. 2006; 9: 977-992. (Pubitemid 44289919)
100. Murtagh FE, Addington-Hall J, Higginson IJ,. The prevalence of symptoms in end-stage renal disease: Systematic review. Adv. Chronic. Kidney Dis. 2007; 14: 82-89.
101. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: A cross-sectional survey of symptom prevalence in stage 5 Chronic Kidney Disease managed without dialysis. J. Palliat. Med. 2007; 10: 1266-1276. (Pubitemid 350308628)
102. Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transplant. 2006; 21: 3495-3505. (Pubitemid 44817100)
103. Davison SN,. The prevalence and management of chronic pain in end stage renal disease. J. Palliat. Med. 2007; 10: 1277-1287. (Pubitemid 350308643)
104. Murphy EI, Murtagh FE, Carey I, Sheerin NS,. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: Use of a short patient-centred assessment tool. Nephron 2009; 111: c74-c80.
105. Lopes AA, Albert EW, Young EW, et al. Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 2004; 66: 2047-2053.
106. Murthagh FE, Weisbord SD,. Symptoms in renal disease; their epidemiology, assessment, and management. In:, Chambers EJ, Brown EA, Germain MJ, (eds). Supportive Care for the Renal Patient, 2nd edn. Oxford: Oxford University Press, 2010; 103-138.
107. Davison SN, Jhangri GS, Johnson JA,. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden. Kidney Int. 2006; 69: 1621-1625.
108. Murtagh F, Weisbord SD,. Symptoms in renal disease: Their epidemiology, assessment, and management. In:, Chambers EJ, Brown E, Germain MJ, (eds). Supportive Care for the Renal Patient, 2nd edn. Oxford: Oxford University Press, 2010; 103-138.
109. Davison SN, Chambers EJ, Ferro CJ,. Management of pain in renal failure. In:, Chambers EJ, Brown E, Germain MJ, (eds). Supportive Care for the Renal Patient, 2nd edn. Oxford: Oxford University Press, 2010; 139-188.
110. Gunal AI, Ozalp G, Yoldas TK, et al. Gabapentin therapy for pruritus in haemodialysis patients: A randomized, placebo-controlled, double-blind trial. Nephrol. Dial. Transplant. 2004; 19: 3137-3139. (Pubitemid 40063517)
111. Naini AE, Harandi AA, Khanbabapours S, et al. Gabapentin: A promising drug for the treatment of uremic pruritus. Saudi J. Kidney Dis. Transpl. 2007; 18: 378-381.
112. Razeghi E, Eskandari D, Ganji MR, et al. Gabapentin and uraemic pruritus in haemodialysis patients. Ren. Fail. 2009; 31: 85-90.
113. Yoshimoto-Furuie K, Yoshimoto K, Tanaka T, et al. Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 1999; 81: 151-159. (Pubitemid 29080426)
114. Chen Y-C, Chiu W-T, Wu M-S,. Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am. J. Kidney Dis. 2006; 48: 69-76.
115. Silva SRB, Viana PCF, Lugon NV, et al. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994; 67: 270-273. (Pubitemid 24177633)
116. Gilcrest BA, Rowe JW, Brown RS, et al. UV phototherapy of uremic pruritus. Ann. Intern. Med. 1979; 91: 17-21.
117. Makhlough A,. Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. Iran. J. Kidney Dis. 2010; 4: 137-140.
118. Breneman DL, Cardone S, Blurmsack RF, et al. Topical capsaicin for treatment of hemodialysis-related pruritus. J. Am. Acad. Dermatol. 1992; 26: 91-94.
119. Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin: A double-blond, crossover study. Neurology 2002; 59: 1573-1579. (Pubitemid 35387065)
120. Thorp ML, Morris CD, Bagby SP,. A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am. J. Kidney Dis. 2001; 38: 104-108. (Pubitemid 32611766)
121. Walters AS, Ondo WG, Dreyluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT: RLS 2: A double-blind, randomized, parallel-group, placebo-controlled study. Mov. Disord. 2004; 19: 1414-1423. (Pubitemid 40104048)
122. Pellecchia MT, Vitale C, Sabatini M, et al. Ropinirole as a treatment for Restless Legs Syndrome in patients on chronic hemodialysus: An open randomized crossover trial versus levodopa sustained release. Clin. Neuropharmacol. 2004; 27: 178-181. (Pubitemid 39121730)
123. Cuko D, Farrell EM, Cohen LM, et al. Psychological and psychiatric considerations in patients with advanced renal disease. In:, Chambers EJ, Brown E, Germain MJ, (eds). Supportive Care for the Renal Patient, 2nd edn. Oxford: Oxford University Press, 2010; 189-202.
124. Keown D,. End of life: The Buddhist view. Lancet 2005; 366: 952-955. (Pubitemid 41265671)
125. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH, and CIDS studies. Eur. Heart J. 2000; 21: 2071-2078. (Pubitemid 32006221)
126. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 2002; 346: 877-883. (Pubitemid 34984635)
127. Herzog CA, Li S, Weinhandl ED, Strief JW, Collins AJ, Gilbertson DT,. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005; 68: 818-825. (Pubitemid 43323139)
128. Sakhuja R, Keebler M, Lai TS, et al. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am. J. Cardiol. 2009; 103: 735-741.
129. Eckart RE, Gula LJ, Reynolds MR, Shry EA, Maisel WH,. Mortality following defibrillator implantation in patients with renal insufficiency. J. Cardiovasc. Electrophysiol. 2006; 17: 940-943.
130. Dasgupta A, Montalvo J, Medendorp S, et al. Increased complication rates of cardiac rhythm management devices in ESKD patients. Am. J. Kidney Dis. 2007; 49: 656-663. (Pubitemid 46654496)
131. Lampert L, Hayes DL, Annas GJ, et al. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing the end of life or requesting withdrawal of therapy. Heart Rhythm. 2010; 7: 1008-1026.
132. Mueller PS, Hook CC, Hayes DL,. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at end of life. Mayo Clin. Proc. 2003; 78: 959-963. (Pubitemid 36936127)
133. Ellershaw J, Wilkinson S,. Care of the Dying: A Pathway to Excellence. Oxford: Oxford University Press, 2003.
134. Douglas C, Murtagh FE, Chambers EJ, Howse M, Ellershaw J,. Symptom management for the adult patient dying with advanced chronic kidney disease: A review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliat. Med. 2009; 23: 103-110.
135. Ellershaw J, Ward C,. Care of the dying patient: The last hours or days of life. BMJ 2003; 326: 30-34. (Pubitemid 36110717)
136. Davison S,. End-of-life preferences and needs: Perceptions of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010; 5: 195-204.
137. Murtagh FEM, Addington-Hall JM, Higginson IJ,. End stage renal disease-A new trajectory of functional decline in the last year of life. J. Am. Geriatr. Soc. 2011; 59: 304-308.
138. Murtagh F, Addington-Hall J,. Symptoms in advanced renal disease-a cross sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J. Palliat. Med. 2007; 10: 1266-1276. (Pubitemid 350308628)
139. DH Renal NSF team and Marie Curie Palliative Care Institute. Guidelines for Liverpool Care Pathway prescribing in advanced kidney disease. 2008.
140. Sirota RA, Kimmel PL, Trichtinger MD, Diamond BF, Stein HD, Yudis M,. Metoclopramide induced parkinsonism in haemodialysis patients. Report of two cases. Arch. Intern. Med. 1986; 146: 2070-2071. (Pubitemid 16006706)
141. May G, Kumar R,. Best evidence topic report. Use of intravenous cyclizine in cardiac chest pain. Emerg. Med. J. 2006; 23: 61-62. (Pubitemid 43056369)
142. Broadbent AM, Khor K, Heaney A,. Palliation and chronic renal failure: Opioid and other palliative medications-dosage guidelines. Prog. Palliat. Care 2003; 11: 183-190. (Pubitemid 37406832)
143. Bauer TM, Ritz R, Haberthur C, et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995; 346: 145-147.
144. Dean M,. Opioids in renal failure and dialysis patients. J. Pain Symptom Manage. 2004; 28: 497-504. (Pubitemid 39422488)
145. Davies G, Kingswood C, Street M,. Pharmacokinetics of opioids in renal dysfunction. Clin. Pharmacokinet. 1996; 31: 410-422. (Pubitemid 26413671)
146. Murtagh FEM, Chai MO, Donohoe P, Edmonds PM, Higginson IJ,. The use of opioid analgesia in end-stage renal disease patients managed without dialysis: Recommendations for practice. J. Pain Palliait. Care Pharmacother. 2007; 21 (2): 5-16. (Pubitemid 47366087)
147. Sullivan K, Johnston L, Colyer C, et al. National Indigenous Palliative Care Needs Study. Canberra, ACT: Australian Government Department of Health and Ageing, 2003.
148. Cass A, Cunningham J, Wang Z, Hoy WE,. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med. J. Aust. 2001; 175: 24-27. (Pubitemid 32631526)
149. Catford J,. Renal Disease in Central Australia-Challenges and Opportunities for Better Health. Burwood, Victoria: Health Strategies Deakin, 1997.
150. Paul B,. Health, Culture, and Community. New York: Russell Sage Foundation, 1955.
151. Muller JH, Desmond B,. Ethical dilemmas in a cross-cultural context: A Chinese example. West. J. Med. 1992; 157: 323-327.
152. ANZDATA 2010. The 33th Annual Report-Data to 2009. Available from URL: http://www.anzdata.org.au/v1/report-2010.html
153. Fried O,. Cross-Cultural Issues in the Medical Management and Nursing Care of Terminally Ill Aboriginal People in Central Australia. Alice Springs, NT: University of Sydney, 2000.
154. Fried O,. Palliative care for patients with end-stage renal failure: Reflections from Central Australia. Palliat. Med. 2003; 17: 514-519. (Pubitemid 37160891)
155. Galla JH,. Clinical practice guidelines on shared decision-making in the appropriate initiation of and withdrawal from dialysis. J. Am. Soc. Nephrol. 2000; 11: 1340-1342. (Pubitemid 30416232)
156. Searight HR, Gafford J,. Cultural diversity at the end of life: Issues and guidelines for family physicians. Am. Fam. Physician 2005; 71: 515-522. (Pubitemid 40194069)
157. Wepa D, (ed.) Cultural Safety in Aotearoa New Zealand. Auckland: Pearson Education, 2005.
158. Hospice NZ. Hospice New Zealand standards for palliative care. 2012. [Cited 5 September 2012.] Available from URL: http://www.hospice.org.nz/cms- show-download.php?id=509.
159. Durie M,. Whaiora: Maori Health Development, 2nd edn. Melbourne: Oxford, 1998.
160. Seymour JE, French J, Richardson E,. Dying matters: Let's talk about it. BMJ 2010; 341: c4860.
161. Nikora LW, Masters-Awatere B, Te Awekotuku N,. Final arrangements following death: Maori indigenous decision making and tangi. J. Community Appl. Soc. Psychol. 2012; 22: 400-413.
162. Clayton JM, Hancock KM, Butow PN, Tattersall MH, Currow DC,. Clinical practice guidelines for communicating prognosis and end of life issues with adults in the advanced stages of life limiting illness, and their caregivers. Med. J. Aust. 2007; 186 (12): S77-108.
163. Blank RH,. End-of-life decision making across cultures. J. Law Med.
164. Kamaka H,. Oranga. Tikanga Recommended Best Practice Policy. Auckland: Auckland District Health Board, 2003.
165. Evans R,. Family Practice, Vol. 20. No. 3 ©. Oxford: Oxford University Press, 2003.
166. Crawford GB,. Palliative care on Kangaroo Island. Aust. J. Rural Health 2000; 8: 35-40.
167. McRae S, Caty S, Nelder M, Picard L,. Palliative care on Manitoulin Island. Views of family caregivers in remote communities. Can. Fam. Physician 2000; 46: 1301-1307.
168. Sach J,. Issues for palliative care in rural Australia. Collegian 1997; 4: 22-27.
169. Hunt R, McCaul K,. Coverage of cancer patients by hospice services, South Australia, 1990 to 1993. Aust. N. Z. J. Public Health 1998; 22: 45-48. (Pubitemid 28245944)
170. Addington-Hall J, McCarthy M,. Dying from cancer: Results of a national population-based investigation. Palliat. Med. 1995; 9: 295-305.
171. Shipman C, Addington-Hall J, Barclay S, et al. Educational opportunities in palliative care: What do general practitioners want? Palliat. Med. 2001; 15: 191-196. (Pubitemid 32479457)
172. Esteva-Canto M, Llobera-Canaves J, Miralles-Xamena J, Bauza-Amengual ML,. Management of terminal cancer patients: Attitudes and training needs of primary health care doctors and nurses. Support. Care Cancer 2000; 8: 464-471.
173. Blair SG, Clayton PA, Cass A, McDonald SP,. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. K.I. 15 August 2012.
174. Gray N, Dent H, McDonald SP,. Renal replacement therapy in rural and urban Australia. Nephrol. Dial. Transplant. 2012; 27: 2069-1969.
175. W Australia. A Pathway for Renal Palliative Care Services in Western Australia. May 2012.
176. Gold Standards Framework. 2006. Available from URL: http://www. goldstandardsframework.nhs.uk/gp-contract.php.
177. Australian Institute of Health and Welfare. End-stage kidney disease in Australia: Total incidence, 2003-2007. Cat. No. PHE 143. Canberra: AIHW. 2011.
178. Murtagh FE, Addington-Hall JM, Higginson IJ,. End-stage renal disease: A new trajectory of functional decline in the last year of life. J. Am. Geriatr. Soc. 2011; 59: 304-308.
179. RACGP. Advance Care Planning. [Cited April 2013.] Available from URL: http://www.racgp.org.au/guidelines/advancecareplans.
180. Chronic Kidney Disease Management in General Practice. [Cited April 2013.] Available from URL: http://www.kidney.org.au/HealthProfessionals/ CKDManagementinGeneralPractice/tabid/789/Default.aspx.
181. DH Renal NSF team and Marie Curie Palliative Care Institute. Guidelines for Liverpool Care Pathway prescribing in advanced kidney disease. 2008.
182. NHS Kidney Care. Caring for Patients with Advanced Kidney Disease at the End of Life-Ten Top Tips. [Cited April 2013.] Available from URL: http://www.kidneycare.nhs.uk/document.php?o=545.
183. ANZDATA. Australia and New Zealand Dialysis and Transplant Registry (30th Annual report. Appendix III New Zealand). 2008., Disney A, MacDonald S, (eds). Adelaide, South Australia.
184. Schena FP,. Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int. 2000; 57 (s74): 39-45.
185. US Renal Data System, USRDS. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2004. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
186. Madhan K,. The epidemic of elderly patients with dialysis-requiring end-stage renal disease in New Zealand. N. Z. Med. J. 2004; 117: U912.
187. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE,. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 2007; 22: 1955-1962. (Pubitemid 47244766)
188. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE,. Functional status of elderly adults before and after initiation of dialysis. N. Engl. J. Med. 2009; 361: 1539-1547.
189. Tattersall J,. Dialysis in the over-80s. Age. Ageing 2005; 34: 100-101. (Pubitemid 40331086)
190. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD,. The epidemic of aging in renal replacement therapy: An update on elderly patients and their outcomes. Clin. Nephrol. 2003; 60: 352-360. (Pubitemid 37407693)
191. Davison SN,. End-of-life care preferences and needs: Perceptions of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010; 5: 195-204.
192. Carson RC, Juszczek M, Davenport A, Burns A,. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease. Clin. J. Am. Soc. Nephrol. 2009; 4: 1610-1619.
193. Morton R, Tong A, Howard K, Snelling P, Webster AC,. The views of patients and carers in treatment decision making for chronic kidney disease: Systematic review and thematic synthesis of qualitative studies. BMJ 2010; 340: c112.
194. ANZDATA. Australia and New Zealand Dialysis and Transplant Registry (34th Annual report. Chapter 4. Method and location of dialysis). 2011., Briggs N, Hurst K, McDonald S, (eds). Adelaide, South Australia.
195. AIHW. 2011. End-stage kidney disease in Australia: Total incidence, 2003-2007. Cat. No. PHE 143. Canberra: AIHW.
196. A Portrait of Health: Key Results of the 2002/2003 New Zealand Health Survey. Wellington: Ministry of Health, New Zealand Government, 2004.
197. Living Standards of Older New Zealanders. A Summary 2001. Wellington: Ministry of Social Development, New Zealand Government, 2004.
198. Edinburgh Renal Unit. Withholding and withdrawal from dialysis (More info). [Cited 15 May 2013.] Available from URL: http://www.edren.org/pages/ edreninfo/witholding-and-withdrawal-from-dialysis/witholding-and-withdrawal- from-dialysis-more-info.php
199. National LCP Renal Steering Group. Guidelines for LCP Drug Prescribing in Advanced Chronic Kidney Disease. [Cited 15 May 2013.] Available from URL: http://www.renal.org/pages/media/guidelines/ national%20lcp%20renal%20symptom%20control%20guidelines%20(05.06.08) %20(printable%20pdf).pdf
200. St George Hospital Renal & Hypertension Unit. Palliative Care Section. [Cited 15 May 2013.] Available from URL: http://stgrenal.med.unsw.edu. au/StGRenalWeb.nsf/page/palliative%20Care%20Section
201. CMAJ. [Cited 15 May 2013.] Available from URL: http://www.cmaj.ca/cgi/ content/full/179/11/1154/DCI
202. Levin A, Hemmelgarn B, Culleton B, et al. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179: 1154-1162.
203. Shared Decision Making in the Appropriate Initiation of and Withdrawal from Dialysis. Clinical Practice Guideline, 2nd edn. Maryville: RPA, 2010.
204. The Renal Association. Renal Replacement Therapy. [Cited 15 May 2013.] Available from URL: http://www.renal.org/Clinical/GuidelinesSection? renalReplacementTherapy.aspx
205. Government document. [Cited 1 Oct 2012.] Available from URL: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications? publicationsPolicyAndGuidance/DH-4101902
206. Conflict Resolution in End of Life Settings (CRELS). [Cited 10 May 2013.] Available from URL: http://www0.health.nsw.gov.au/pubs/2010/pdf/conflict- resolution.pdf
207. Arnold RM, Zeidel ML,. Dialysis in frail elders-a role for palliative care. N. Engl. J. Med. 2009; 361: 1597-1598. [Comment Editorial].
208. Murtagh FE, Addington-Hall JM, Donohoe P, Higginson IJ,. Symptom management in patients with established renal failure managed without dialysis. EDTNA ERCA J. 2006; 32: 93-98. [Research Support, Non-U.S. Gov't Review].
209. Murtagh FE, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: A cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J. Palliat. Med. 2007; 10: 1266-1276. (Pubitemid 350308628)
210. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE,. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 2007; 22: 1955-1962. [Comparative Study]. (Pubitemid 47244766)
211. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K,. Survival of elderly patients with stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 2011; 26: 1608-1614. [Comparative Study].
212. Yong DS, Kwok AO, Wong DM, Suen MH, Chen WT, Tse DM,. Symptom burden and quality of life in end-stage renal disease: A study of 179 patients on dialysis and palliative care. Palliat. Med. 2009; 23: 111-119.
213. Holley JL, Carmody SS, Moss AH, et al. The need for end-of-life care training in nephrology: National survey results of nephrology fellows. Am. J. Kidney Dis. 2003; 42: 813-820. [Research Support, Non-U.S. Gov't]. (Pubitemid 37187383)
214. Weisbord SD, Fried LF, Mor MK, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 2007; 2: 960-967. [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.].
215. Bailie GR, Mason NA, Bragg-Gresham JL, Gillespie BW, Young EW,. Analgesic prescription patterns among hemodialysis patients in the DOPPS: Potential for underprescription. Kidney Int. 2004; 65: 2419-2425. [Multicenter Study Research Support, Non-U.S. Gov't]. (Pubitemid 38670028)
216. Fine A, Fontaine B, Kraushar MM, Rich BR,. Nephrologists should voluntarily divulge survival data to potential dialysis patients: A questionnaire study. Perit. Dial. Int. 2005; 25: 269-273. [Research Support, Non-U.S. Gov't]. (Pubitemid 40724207)
217. Holley JL, Davison SN, Moss AH,. Nephrologists' changing practices in reported end-of-life decision-making. Clin. J. Am. Soc. Nephrol. 2007; 2: 107-111. [Research Support, Non-U.S. Gov't].
218. Davison SN, Simpson C,. Hope and advance care planning in patients with end stage renal disease: Qualitative interview study. BMJ 2006; 333: 886. [Research Support, Non-U.S. Gov't].
219. Davison SN,. End-of-life care preferences and needs: Perceptions of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010; 5: 195-204.
220. Price CA,. Resources for planning palliative and end-of-life care for patients with kidney disease. Nephrol. Nurs. J. 2003; 30: 649-656. [Review].
221. Compton A, Provenzano R, Johnson CA,. The nephrology nurse's role in improved care of patients with chronic kidney disease. Nephrol. Nurs. J. 2002; 29: 331-336. [Research Support, Non-U.S. Gov't Review].
222. Young S,. Rethinking and integrating nephrology palliative care: A nephrology nursing perspective. CANNT J. 2009; 19: 36-44. [Review].
223. Wee B, Hillier R, Coles C, Mountford B, Sheldon F, Turner P,. Palliative care: A suitable setting for undergraduate interprofessional education. Palliat. Med. 2001; 15: 487-492. [Research Support, Non-U.S. Gov't]. (Pubitemid 33133957)
224. Keesing S,. Is occupation missing from occupational therapy in palliative care? Aust. Occup. Ther. J. 2011; 58: 329-336.
225. Davison SN, Torgunrud C,. The creation of an advance care planning process for patients with ESRD. Am. J. Kidney Dis. 2007; 49: 27-36. [Research Support, Non-U.S. Gov't Review]. (Pubitemid 44918174)
226. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 2012; 184: E277-283. [Multicenter Study Research Support, Non-U.S. Gov't].
227. Laakso L,. The role of physiotherapy in palliative care. Aust. Fam. Physician 2006; 35: 781.
228. Meredith PJ,. Has undergraduate education prepared occupational therapy students for possible practice in palliative care? Aust. Occup. Ther. J. 2010; 57: 224-232.